SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) July 11, 2000
MEDICORE, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Florida 0-6906 59-0941551
---------------------------- ------------- -------------------
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)
2337 West 76th Street, Hialeah, Florida 33016
---------------------------------------- ----------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (305) 558-4000
--------------
<PAGE>
Item 5. Other Events
On July 11, 2000, the board appointed Lawrence E. Jaffe to fill the
vacancy in the Class 1 director category, the other Class 1 director being
Peter D. Fischbein. Class 1 directors are to be considered for re-election
by shareholders at the 2002 annual meeting. Mr. Jaffe is a member of the
firm of Jaffe Freedman & Hait, LLC, and has been Secretary and counsel to
the Company for many years.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits
(a) Financial Statements of Businesses Acquired
Not Applicable
(b) Pro Forma Financial Information
Not Applicable
(c) Exhibits
None
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDICORE, INC.
/s/ Thomas K. Langbein
By--------------------------------
THOMAS K. LANGBEIN, Chairman
of the Board, CEO and President
Dated: July 20, 2000
